vs

Side-by-side financial comparison of ALPHA & OMEGA SEMICONDUCTOR Ltd (AOSL) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

ALPHA & OMEGA SEMICONDUCTOR Ltd is the larger business by last-quarter revenue ($162.3M vs $83.1M, roughly 2.0× PROCEPT BioRobotics Corp). ALPHA & OMEGA SEMICONDUCTOR Ltd runs the higher net margin — -8.2% vs -38.1%, a 29.9% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -6.3%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 4.0%).

Alpha & Omega Semiconductor Ltd designs, manufactures and markets a broad portfolio of power semiconductors, including power MOSFETs, IGBTs, analog ICs and power management modules. Its products are applied across consumer electronics, industrial equipment, automotive systems, telecom and computing segments, with sales networks covering major global markets.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

AOSL vs PRCT — Head-to-Head

Bigger by revenue
AOSL
AOSL
2.0× larger
AOSL
$162.3M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+26.5% gap
PRCT
20.2%
-6.3%
AOSL
Higher net margin
AOSL
AOSL
29.9% more per $
AOSL
-8.2%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
4.0%
AOSL

Income Statement — Q2 FY2026 vs Q1 FY2026

Metric
AOSL
AOSL
PRCT
PRCT
Revenue
$162.3M
$83.1M
Net Profit
$-13.3M
$-31.6M
Gross Margin
21.5%
64.9%
Operating Margin
-8.4%
-4.1%
Net Margin
-8.2%
-38.1%
Revenue YoY
-6.3%
20.2%
Net Profit YoY
-101.0%
-27.9%
EPS (diluted)
$-0.45
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AOSL
AOSL
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$162.3M
$76.4M
Q3 25
$182.5M
$83.3M
Q2 25
$176.5M
$79.2M
Q1 25
$164.6M
$69.2M
Q4 24
$173.2M
$68.2M
Q3 24
$181.9M
$58.4M
Q2 24
$161.3M
$53.4M
Net Profit
AOSL
AOSL
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-13.3M
$-29.8M
Q3 25
$-2.1M
$-21.4M
Q2 25
$-77.1M
$-19.6M
Q1 25
$-10.8M
$-24.7M
Q4 24
$-6.6M
$-18.9M
Q3 24
$-2.5M
$-21.0M
Q2 24
$-2.7M
$-25.6M
Gross Margin
AOSL
AOSL
PRCT
PRCT
Q1 26
64.9%
Q4 25
21.5%
60.6%
Q3 25
23.5%
64.8%
Q2 25
23.4%
65.4%
Q1 25
21.4%
63.9%
Q4 24
23.1%
64.0%
Q3 24
24.5%
63.2%
Q2 24
25.7%
59.0%
Operating Margin
AOSL
AOSL
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-8.4%
-40.6%
Q3 25
-2.5%
-27.8%
Q2 25
-6.6%
-28.0%
Q1 25
-6.5%
-39.7%
Q4 24
-3.4%
-28.9%
Q3 24
-0.1%
-38.4%
Q2 24
-0.9%
-50.3%
Net Margin
AOSL
AOSL
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-8.2%
-39.1%
Q3 25
-1.2%
-25.7%
Q2 25
-43.7%
-24.7%
Q1 25
-6.6%
-35.8%
Q4 24
-3.8%
-27.6%
Q3 24
-1.4%
-35.9%
Q2 24
-1.7%
-48.0%
EPS (diluted)
AOSL
AOSL
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.45
$-0.54
Q3 25
$-0.07
$-0.38
Q2 25
$-2.61
$-0.35
Q1 25
$-0.37
$-0.45
Q4 24
$-0.23
$-0.34
Q3 24
$-0.09
$-0.40
Q2 24
$-0.09
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AOSL
AOSL
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$196.3M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$818.8M
$347.7M
Total Assets
$1.0B
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AOSL
AOSL
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$196.3M
$286.5M
Q3 25
$223.5M
$294.3M
Q2 25
$153.1M
$302.7M
Q1 25
$169.4M
$316.2M
Q4 24
$182.6M
$333.7M
Q3 24
$176.0M
$196.8M
Q2 24
$175.1M
$214.1M
Total Debt
AOSL
AOSL
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$14.9M
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$26.7M
$51.4M
Stockholders' Equity
AOSL
AOSL
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$818.8M
$365.9M
Q3 25
$834.1M
$380.3M
Q2 25
$822.3M
$385.8M
Q1 25
$886.3M
$389.2M
Q4 24
$902.6M
$402.2M
Q3 24
$895.3M
$241.2M
Q2 24
$891.6M
$251.8M
Total Assets
AOSL
AOSL
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$1.0B
$508.1M
Q3 25
$1.0B
$511.5M
Q2 25
$1.0B
$513.1M
Q1 25
$1.1B
$519.4M
Q4 24
$1.1B
$534.0M
Q3 24
$1.1B
$374.1M
Q2 24
$1.1B
$374.4M
Debt / Equity
AOSL
AOSL
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.02×
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.03×
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AOSL
AOSL
PRCT
PRCT
Operating Cash FlowLast quarter
$-8.1M
Free Cash FlowOCF − Capex
$-23.1M
FCF MarginFCF / Revenue
-14.2%
Capex IntensityCapex / Revenue
9.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-40.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AOSL
AOSL
PRCT
PRCT
Q1 26
Q4 25
$-8.1M
$-10.3M
Q3 25
$10.2M
$-6.6M
Q2 25
$-2.8M
$-15.0M
Q1 25
$7.4M
$-17.0M
Q4 24
$14.1M
$-32.4M
Q3 24
$11.0M
$-18.8M
Q2 24
$7.1M
$-15.7M
Free Cash Flow
AOSL
AOSL
PRCT
PRCT
Q1 26
Q4 25
$-23.1M
$-12.2M
Q3 25
$420.0K
$-9.5M
Q2 25
$-17.2M
$-17.8M
Q1 25
$-1.1M
$-18.8M
Q4 24
$6.6M
$-33.6M
Q3 24
$4.1M
$-19.0M
Q2 24
$-210.0K
$-16.8M
FCF Margin
AOSL
AOSL
PRCT
PRCT
Q1 26
Q4 25
-14.2%
-15.9%
Q3 25
0.2%
-11.4%
Q2 25
-9.7%
-22.5%
Q1 25
-0.6%
-27.2%
Q4 24
3.8%
-49.2%
Q3 24
2.3%
-32.6%
Q2 24
-0.1%
-31.4%
Capex Intensity
AOSL
AOSL
PRCT
PRCT
Q1 26
Q4 25
9.2%
2.4%
Q3 25
5.4%
3.4%
Q2 25
8.1%
3.5%
Q1 25
5.1%
2.7%
Q4 24
4.3%
1.7%
Q3 24
3.8%
0.4%
Q2 24
4.5%
2.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AOSL
AOSL

Power Discrete$101.0M62%
Power Ic$58.8M36%
Packaging And Testing Services$2.5M2%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons